Injective (INJ) has surpassed the $10 mark, continuing its 10-day winning streak. The recent surge in price can be attributed to the launch of a new product feature on the Injective decentralized exchange (DEX). This feature allows users to trade “pre-launch” tokens before they are officially listed or launched. Since the announcement, hundreds of new users have joined the Injective network, leading to a spike in network growth.
Increased demand for the native token and products on the platform has driven the price of INJ to a 20-month high. However, on-chain data suggests that the media hype surrounding this rally may be reaching euphoric levels. In the past, extreme media frenzy has been an early warning sign of a potential price reversal.
While a mild retracement is possible due to profit booking by holders, the organic network growth provides support at a relatively high price level. The presence of a buy-wall at $8.50 further supports this forecast. On the other hand, if the bulls continue to push the price upwards, they may encounter resistance at $12.
In conclusion, while there is potential for a retracement in INJ’s price, the bullish momentum driven by new users and product features could lead to further gains in the future.
Subscribe to our Social Media for Exclusive Crypto News and Insights 24/7!
Hot Take: INJ’s Price Surge Fueled by New Product Feature and Increased Network Growth
